Cargando…
TNFerade, an innovative cancer immunotherapeutic
Tumor necrosis factor-α (TNF-α) is a chemokine with effective tumoricidal properties. However, severe systemic toxicity limits its use of as anticancer agent. TNFerade is a novel replication deficient adenovector based gene therapy, which enables the radiation inducible translation of human TNF-α ge...
Autor principal: | Kali, Arunava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621666/ https://www.ncbi.nlm.nih.gov/pubmed/26600634 http://dx.doi.org/10.4103/0253-7613.165190 |
Ejemplares similares
-
Reference management: A critical element of scientific writing
por: Kali, Arunava
Publicado: (2016) -
Endocan: A novel circulating proteoglycan
por: Kali, Arunava, et al.
Publicado: (2014) -
Cost-effective innovation of locally assembled mannequins for undergraduate skill development in parenteral drug administration
por: Mani, Susan, et al.
Publicado: (2020) -
Preclinical screening methods in cancer
por: Kumar, Sachin, et al.
Publicado: (2016) -
Applications of Diagnostic Ultrasonography for Cancer Survivor Care
por: Shyu, Shaw-Gang
Publicado: (2020)